Kenneth Galbraith - Jan 15, 2022 Form 3 Insider Report for Zymeworks Inc. (ZYME)

Role: Chair, President & CEO, Director
Signature: /s/ Daniel Dex, Attorney-in-Fact
Stock symbol: ZYME
Transactions as of: Jan 15, 2022
Transactions value $: $0
Form type: 3
Date filed: 1/18/2022, 05:20 AM
Previous filing: May 17, 2021
Next filing: Dec 23, 2022

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney